Fund shareholders of EyePoint Inc
ISIN US30233G2093 · United States · LEI 549300QE1RU34T50MR69
- Fund shareholders
- 158
- Of which ETFs
- 38 120 other funds
- Value held
- 303.5M $
- Share of capital
- 26.0 % of 86.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Victory Extended Market Index Fund Victory Portfolios III | 8,381 | 110.6K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 8,127 | 104.8K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 6,511 | 83.9K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 6,134 | 79.1K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 6,118 | 80.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 6,062 | 80K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 6,035 | 106K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 5,770 | 74.4K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 5,763 | 101.2K $ | 0.36 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 5,757 | 74.2K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| DWS Small Mid Cap Growth VIP DEUTSCHE DWS VARIABLE SERIES II | 5,600 | 72.2K $ | 0.16 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 5,412 | 69.8K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Wellington Small Cap Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 5,387 | 69.4K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 5,333 | 68.7K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 5,225 | 67.4K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 5,134 | 67.8K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 5,129 | 67.7K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 4,809 | 62K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 4,667 | 82K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 4,651 | 81.7K $ | 0.02 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 4,637 | 81.4K $ | 0.11 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 3,822 | 67.1K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,564 | 47K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 3,466 | 44.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,277 | 57.5K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 3,236 | 42.7K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 3,049 | 53.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 3,000 | 38.7K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 2,976 | 39.3K $ | 1.17 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 2,531 | 33.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,523 | 32.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,100 | 27.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 2,088 | 27.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,858 | 23.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,774 | 22.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 1,530 | 19.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,427 | 25.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,348 | 17.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 1,107 | 14.6K $ | 0.40 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 900 | 11.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 874 | 11.5K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 690 | 8.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 625 | 8.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 437 | 5.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 375 | 4.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 343 | 4.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 298 | 3.9K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 259 | 3.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 2.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 196 | 2.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 173 | 2.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 157 | 2.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 148 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 141 | 1.9K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 103 | 1.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 78 | 1.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 23 | 403.9 $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 20 | 257.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.66 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.59 % | as of Mar 31, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 1.52 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 1.43 % | as of Apr 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.18 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.17 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.01 % | as of Mar 31, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 0.99 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.91 % | as of Apr 30, 2026 ↗ |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 0.81 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 158 | +9 | 22,435,174 | +9.5 % |
| 2026Q1 | 149 | +8 | 20,497,199 | +19.3 % |
| 2025Q4 | 141 | +9 | 17,175,341 | +4.4 % |
| 2025Q3 | 132 | -8 | 16,452,715 | -4.2 % |
| 2025Q2 | 140 | +6 | 17,169,593 | +4.0 % |
| 2025Q1 | 134 | -9 | 16,510,707 | +1.5 % |
| 2024Q4 | 143 | +2 | 16,272,534 | +40.6 % |
| 2024Q3 | 141 | -17 | 11,573,451 | -6.0 % |
| 2024Q2 | 158 | +30 | 12,307,718 | +24.0 % |
| 2024Q1 | 128 | +13 | 9,922,628 | +33.6 % |
| 2023Q4 | 115 | 7,428,303 |
Institutional managers
179 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8,296,375 | 106.9M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 8,265,000 | 106.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,177,337 | 92.5M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 5,669,589 | 73.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 5,048,598 | 65.1M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 3,601,168 | 46.4M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,300,000 | 42.5M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 3,142,437 | 40.5M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 2,825,000 | 36.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,097,202 | 27M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,983,665 | 25.6M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,905,875 | 24.6M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 1,738,378 | 22.4M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,438,737 | 18.5M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 1,354,800 | 17.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,245,583 | 16.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,096,109 | 14.1M $ | as of Mar 31, 2026 |
| Essex Woodlands Management, Inc. | 1,084,857 | 14M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 1,069,147 | 13.8M $ | as of Mar 31, 2026 |
| 5AM Venture Management, LLC | 1,050,000 | 13.5M $ | as of Mar 31, 2026 |
| Rosalind Advisors, Inc. | 1,036,737 | 13.4M $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 912,594 | 11.8M $ | as of Mar 31, 2026 |
| HSBC HOLDINGS PLC | 833,455 | 10.7M $ | as of Mar 31, 2026 |
| STEMPOINT CAPITAL LP | 810,764 | 10.5M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 795,000 | 10.2M $ | as of Mar 31, 2026 |
Declared shareholders of EyePoint Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Commodore Capital LP and 3 others | 5.10 % | 4,250,000 | as of May 27, 2026 · SCHEDULE 13G |
| Adage Capital Management, L.P. and 2 others | 3.96 % | 3,300,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Paradigm BioCapital Advisors LP and 3 others | 3.80 % | 3,142,437 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of EyePoint Inc". https://titelia.com/en/stocks/eyepoint-inc-US30233G2093